Maria T. Rossi
Brescia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Letter: From Persistence to Remission: The Effectiveness of Upadacitinib in a Case of Longstanding Refractory Erythroderma.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: August 11, 2025
European Guideline (EuroGuiDerm) on atopic eczema: Living update.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 12, 2025
Happiness across the borders-A cross-sectional study among patients with psoriasis and atopic dermatitis in Europe.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 14, 2024
Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus.
Journal: Dermatology and therapy
Published: January 19, 2024
Occupational asbestos exposure and ovarian cancer: updated systematic review.
Journal: Occupational medicine (Oxford, England)
Published: December 10, 2023
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: October 10, 2023
A technology transfer journey to a model-driven access control system.
Journal: International journal on software tools for technology transfer : STTT
Published: January 13, 2023
First update of the living European guideline (EuroGuiDerm) on atopic eczema.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: December 13, 2022
European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 17, 2022
European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 17, 2022
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: February 07, 2022
Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experience.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: December 18, 2021
Last Updated: 09/26/2026